1. Johnson NP, Hummelshoj L. Consensus on current management of endometriosis. Hum Reproduct [Oxford, England]. 2013; 28(6): 1552-68. doi: 10.1093/humrep/det050 PMid: 23528916

2. Agarwal SK, Chapron C, Giudice LC, Laufer MR, Leyland N, Missmer SA, et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol 2019; 220(4): 354. e1-e12. doi: 10.1016/j.ajog.2018.12.039. PMid: 30625295.

3. Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Marshall LM, Hunter DJ. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol 2004; 160(8):784-96. doi: 10.1093/aje/kwh275. PMid: 15466501.

4. Sarria-Santamera A, Orazumbekova B, Terzic M. Systematic Review and Meta-Analysis of Incidence and Prevalence of Endometriosis. 2020; 9(1). doi: 10.3390/healthcare9010029. PMid: 33396813. PMCid: PMC7824417.

5. Wolfhagen N, Simons NE, de Jong KH, van Kesteren PJM, Simons MP. Inguinal endometriosis, a rare entity of which surgeons should be aware: clinical aspects and long-term follow-up of nine cases. Hernia: the journal of hernias and abdominal wall surgery. 2018; 22(5):881-6. doi: 10.1007/s10029-018-x. PMid: 30078093.

6. Collinet P, Fritel X, Revel-Delhom C, Ballester M, Bolze PA, Borghese B, et al. Management of endometriosis: CNGOF/HAS clinical practice guidelines - Short version. J Gynecol Obstet Hum Reproduct 2018; 47(7): 265-74. doi: 10.1016/j.jogoh.2018.06.003. PMid: 29920379.

7. Ahn SH, Singh V, Tayade C. Biomarkers in endometriosis: challenges and opportunities. Fertil Steril 2017; 107(3): 523-32. doi: 10.1016/j.fertnstert.2017.01.009. PMid: 28189296.

8. Cramer DW, Wilson E, Stillman RJ, Berger MJ, Belisle S, Schiff I, et al. The relation of endometriosis to menstrual characteristics, smoking, and exercise. Jama. 1986;255(14):1904-8 doi:10.1001/jama.1986.03370140102032 PMid:3951117.

9. Falcone T, Flyckt R. Clinical management of endometriosis. Obstet Gynecol 2018; 131(3):557-71. doi: 10.1097/AOG.0000000000002469. PMid: 29420391.

10. Parazzini F, LA Vecchia C, Franceschi S, Negri E, Cecchetti G. Risk factors for endometrioid, mucinous and serous benign ovarian cysts. Int J Epidemiol. 1989; 18(1):108-12. doi: 10.1093/ije/18.1.108. PMid: 2722352.

11. Molgaard CA, Gresham L, Golbeck AL. Current concepts in endometriosis. Western J Med 1985; 143(1):42. PMid: 2930948; PMCid: PMC1306221.

12. Nnoaham KE, Hummelshoj L, Webster P, d’Hooghe T, de Cicco Nardone F, de Cicco Nardone C, et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertility Sterility. 2011; 96(2): 366-73. e8. doi: 10.1016/j.fertnstert.2011.05.090. PMid: 21718982.

13. Rogers PA, D’Hooghe TM, Fazleabas A, Giudice LC, Montgomery GW, Petraglia F, et al. Defining future directions for endometriosis research: workshop report from the 2011 World Congress of Endometriosis in Montpellier, France. Reprod Sci. 2013; 20(5):483-99. doi: 10.1177/1933719113477495. PMid: 23427182. PMCid: PMC3635070.

14. Haas D, Shebl O, Shamiyeh A, Oppelt P. The rASRM score and the Enzian classification for endometriosis: their strengths and weaknesses. Acta obstetricia et gynecologica Scandinavica. 2013; 92 (1):3-7. doi: 10.1111/aogs.12026. PMid: 23061819

15. Metzemaekers J, Haazebroek P, Smeets M, English J, Blikkendaal M, Twijnstra A, et al. EQUSUM: Endometriosis QUality and grading instrument for surgical performance: proof of concept study for automatic digital registration and classification scoring for r-ASRM, EFI and Enzian. Hum Reprod Open. 2020; 2020(4): hoaa053. doi: 10.1093/hropen/hoaa053. PMid: 33409380. PMCid: PMC7772248.

16. Leonardi M, Espada M, Vanza K, Choi S, Chou D, Chang T, et al. Ultrasound is highly accurate at predicting the american society of reproductive medicine (AARM) stage of endometriosis. J Minimally Invasive Gynecol 2019; 26(7): S70-S1. doi: 10.1093/humrep/deab085. PMid: 33864088.

17. Abrão MS, Andres MP, Barbosa RN, Bassi MA, Kho RM. Optimizing perioperative outcomes with selective bowel resection following an algorithm based on preoperative imaging for bowel endometriosis. J Minim Invasive Gynecol 2020; 27 (4):883-91. doi: 10.1016/j.jmig.2019.06.010. PMid: 31238150.

18. Keckstein J, Ulrich U, Possover M, Schweppe K. ENZIAN-classifikation der tief infiltrierenden Endometriose. Zentralbl Gynäkol. 2003; 125:291. doi: 10.1055/s-2005-836904. PMid: 16195969.

19. Haas D, Shebl O, Shamiyeh A, Oppelt P. The rASRM score and the Enzian classification for endometriosis: their strengths and weaknesses. Acta Obstet Gynecol Scand. 2013; 92(1): 3-7. doi: 10.1111/aogs.12026. PMid: 23061819.

20. Adamson GD, Pasta DJ. Endometriosis fertility index: the new, validated endometriosis staging system. Fertil Steril 2010;94(5):1609-15. doi: 10.1016/j.fertnstert.2009.09.035. PMid: 19931076.

21. Saha R, Marions L, Tornvall P. Validity of self-reported endometriosis and endometriosis-related questions in a Swedish female twin cohort. Fertil Steril 2017; 107(1):174-8. e2. doi: 10.1016/j.fertnstert.2016.09.038. PMid: 27793372.

22. Ilangavan K, Kalu E. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril. 2010; 93(3): e10. doi: 10.1016/j.fertnstert.2008.04.056. PMid: 18684448.

23. DiVasta AD, Vitonis AF, Laufer MR, Missmer SA. Spectrum of symptoms in women diagnosed with endometriosis during adolescence vs adulthood. Am J Obstet Gynecol 2018; 218(3): 324. e1-. e11. doi: 10.1016/j.ajog.2017.12.007. PMid: 29247637.

24. Ashrafi M, Sadatmahalleh SJ, Akhoond MR, Talebi M. Evaluation of risk factors associated with endometriosis in infertile women. Int J Fertil Steril 2016; 10(1): 11. doi: 10.22074/ijfs.2016.4763. PMid: 27123195. PMCid: PMC4845520.

25. Nnoaham KE, Hummelshoj L, Kennedy SH, Jenkinson C, Zondervan KT, Consortium WERFWsHSS. Developing symptom-based predictive models of endometriosis as a clinical screening tool: results from a multicenter study. Fertil Steril 2012; 98 (3):692-701. e5. doi: 10.1016/j.fertnstert.2012.04.022. PMid: 22657249. PMCid: PMC3679490.

26. Heitmann RJ, Langan KL, Huang RR, Chow GE, Burney RO. Premenstrual spotting of≥ 2 days is strongly associated with histologically confirmed endometriosis in women with infertility. Am J Obstet Gynecol 2014; 211 (4):358. e1-. e6. doi: 10.1016/j.ajog.2014.04.041. PMid: 2479931.

27. Agarwal SK, Chapron C, Giudice LC, Laufer MR, Leyland N, Missmer SA, et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol 2019; 220(4): 354.e1-. e12. doi: 10.1016/j.ajog.2018.12.039. PMid: 30625295.

28. Smolarz B, Szyłło K, Romanowicz H. Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics (review of literature). Int J Mol Sci 2021; 22(19): 10554. doi: 10.3390/ijms221910554. PMid: 34638893. PMCid: PMC8508982.

29. Sampson JA. Endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol. 1927; 14: 422-69.

30. Sampson JA. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol. 1927;3(2):93. PMid: 19969738; PMCid: PMC1931779.

31. Vercellini P, Aimi G, De Giorgi O, Maddalena S, Carinelli S, Crosignani PG. Is cystic ovarian endometriosis an asymmetric disease? BJOG: An Int J Obstet Gynaecol 1998; 105(9): 1018-21. doi: 10.1111/j.1471-0528.1998.tb10267.x. PMid: 9763055.

32. Sampson JA. Perforating hemorrhagic (chocolate) cysts of the ovary: their importance and especially their relation to pelvic adenomas of endometrial type (adenomyoma of the uterus, rectovaginal septum, sigmoid, etc.). Arch Surg 1921; 3(2):245-323. doi:10.1001/archsurg.1921.01110080003001.

33. Batt RE, Mitwally MF. Endometriosis from thelarche to midteens: pathogenesis and prognosis, prevention and pedagogy. J Pediatr Adolesc Gynecol 2003; 16(6): 337-47. doi: 10.1016/j.jpag.2003.09.008. PMid: 14642954.

34. Fujii S. Secondary müllerian system and endometriosis. Am J Obstet Gynecol. 1991; 165(1): 219-25. doi: 10.1016/0002-9378(91)90255-p. PMid: 1853900.

35. Laganà AS, Garzon S, Götte M, Viganò P, Franchi M, Ghezzi F, et al. The pathogenesis of endometriosis: molecular and cell biology insights. Int J Mol Sci. 2019; 20(22):5615. doi: 10.3390/ijms20225615. PMid: 31717614; PMCid: PMC6888544.

36. Nawroth F, Rahimi G, Nawroth C, Foth D, Ludwig M, Schmidt T. Is there an association between septate uterus and endometriosis? Hum Reprod. 2006; 21(2): 542-4. doi: 10.1093/humrep/dei344. PMid: 16210382.

37. Signorile PG, Baldi F, Bussani R, D'Armiento M, De Falco M, Baldi A. Ectopic endometrium in human foetuses is a common event and sustains the theory of müllerianosis in the pathogenesis of endometriosis, a disease that predisposes to cancer. J Exp Clin Cancer Res 2009; 28(1):1-5. doi: 10.1186/1756-9966-28-49. PMid: 19358700; PMCid: PMC2671494.

38. Reese K, Reddy S, Rock J. Endometriosis in an adolescent population: the Emory experience. J Pediatr Adolesc Gynecol. 1996; 9(3):125-8. doi: 10.1016/s1083-3188(96)70021-9. PMid: 8795787.

39. Vercellini P, Abbiati A, Viganò P, Somigliana E, Daguati R, Meroni F, et al. Asymmetry in distribution of diaphragmatic endometriotic lesions: evidence in favour of the menstrual reflux theory. Hum Reprod 2007; 22(9): 2359-67. doi: 10.1093/humrep/dem224. PMid: 17636274.

40. Rei C, Williams T, Feloney M. Endometriosis in a man as a rare source of abdominal pain: a case report and review of the literature. Case Rep Obstet Gynecol. 2018; 2018: 2083121. doi: 10.1155/2018/2083121. PMid: 29670782; PMCid: PMC5833878.

41. Winterhager E. Role of steroid hormones: estrogen and endometriosis. Endometriosis: Sci Pract. 2011:140-4. doi.org/10.1002/9781444398519.ch13.

42. Asghari S, Valizadeh A, Aghebati-Maleki L, Nouri M, Yousefi M. Endometriosis: Perspective, lights, and shadows of etiology. Biomed Pharmacother. 2018; 106:163-74. doi: 10.1016/j.biopha.2018.06.109. PMid: 29958140.

43. Wang Y, Nicholes K, Shih I-M. The origin and pathogenesis of endometriosis. Ann Rev Pathol 2020; 15:71. doi: 10.1146/annurev-pathmechdis-012419-032654. PMid: 31479615; PMCid: PMC798095.

44. Maruyama T, Yoshimura Y. Molecular and cellular mechanisms for differentiation and regeneration of the uterine endometrium. Endocr J 2008; 55(5): 795-810. doi: 10.1507/endocrj. k08e-067. PMid: 18580040.

45. Liang Y, Xie H, Wu J, Liu D, Yao S. Villainous role of estrogen in macrophage-nerve interaction in endometriosis. Reprod Biol Endocrinol 2018; 16(1): 1-11. doi: 10.1186/s12958-018-0441-z. PMid: 30518376; PMCid: PMC6282253.

46. Burns KA, Rodriguez KF, Hewitt SC, Janardhan KS, Young SL, Korach KS. Role of estrogen receptor signaling required for endometriosis-like lesion establishment in a mouse model. Endocrinology. 2012; 153(8):3960-71. doi: 10.1210/en.2012-1294. PMid: 22700766; PMCid: PMC3404357.

47. Han SJ, Jung SY, Wu S-P, Hawkins SM, Park MJ, Kyo S, et al. Estrogen receptor β modulates apoptosis complexes and the inflammasome to drive the pathogenesis of endometriosis. Cell. 2015; 163 (4): 960-74. doi: 10.1016/j.cell.2015.10.034. PMid: 26544941; PMCid: PMC4640214.

48. Patel BG, Rudnicki M, Yu J, Shu Y, Taylor RN. Progesterone resistance in endometriosis: origins, consequences and interventions. Acta Obstet Gynecol Scand. 2017; 96(6):623-32. doi: 10.1111/aogs.13156. PMid: 28423456.

49. Li Y, Adur MK, Kannan A, Davila J, Zhao Y, Nowak RA, et al. Progesterone alleviates endometriosis via inhibition of uterine cell proliferation, inflammation and angiogenesis in an immunocompetent mouse model. PloS One 2016; 11(10): e0165347. doi: 10.1371/journal.pone.0165347. PMid: 27776183; PMCid: PMC5077092.

50. Jęda-Golonka A, Witek A, Paul-Samojedny M, Kruszniewska-Rajs C, editors. Analysis of correlation between transcription activity of estrogen-dependent genes of cytochrome P450 and profile of estrogen receptor in endometrial adenocarcinoma. Ann Acad Med Silesien; 2020; 47(24).

51. Liu Y, Li H, Zhao C, Jia H. MicroRNA-101 inhibits angiogenesis via COX-2 in endometrial carcinoma. Mol Cell Biochem. 2018; 448(1):61-9. doi: 10.1007/s11010-018-3313-0. PMid: 29404887.

52. Nannini M, Dondi G, Santini D, De Leo A, Dei Tos AP, Zamagni C, et al. A single-centre experience on the management of adenosarcoma: a successful report of an integrated medical and surgical approach. Clin Med Insight: Oncol. 2018; 12: 1179554918782477. doi: 10.1177/1179554918782477. PMid: 29977120; PMCid: PMC6024524.

53. Hanley GE, Pearce CL, Talhouk A, Kwon JS, Finlayson SJ, McAlpine JN, et al. Outcomes from opportunistic salpingectomy for ovarian cancer prevention. JAMA Netw Open. 2022; 5(2): e2147343 doi: 10.1001/jamanetworkopen.2021.47343. PMid: 35138400; PMCid: PMC8829665.

54. Moore M, McCluggage WG. Uterine endometrial stromal tumors with limited infiltration: first report of a case series indicating potential for malignant behavior. Int J Gynecol Pathol 2020; 39(3): 221-6. doi: 10.1097/PGP.0000000000000593. PMid: 30807369.

55. Zubrzycka A, Zubrzycki M, Perdas E, Zubrzycka M. Genetic, epigenetic, and steroidogenic modulation mechanisms in endometriosis. J Clin Med 2020; 9(5): 1309. doi: 10.3390/jcm9051309. PMid: 32370117; PMCid: PMC7291215.

56. Stefansson H, Geirsson R, Steinthorsdottir V, Jonsson H, Manolescu A, Kong A, et al. Genetic factors contribute to the risk of developing endometriosis. Hum Reprod. 2002; 17(3):555-9. doi: 10.1093/humrep/17.3.555. PMIid: 11870102.

57. Tokushige N, Markham R, Russell P, Fraser IS. Nerve fibres in peritoneal endometriosis. Hum Reprod. 2006; 21(11):3001-7. doi: 10.1093/humrep/del260. PMid: 16950827.

58. Hadfield RM, Mardon HJ, Barlow DH, Kennedy SH. Endometriosis in monozygotic twins. Fertil Steril. 1997; 68(5):941-2. doi: 10.1016/s0015-0282(97)00359-2. PMid: 9389831.

59. Meirson T, Gil-Henn H, Samson AO. Invasion and metastasis: The elusive hallmark of cancer. Oncogene. 2020; 39(9):2024-6. doi: 10.1038/s41388-019-1110-1. PMid: 31745295.

60. Durmus S, Gelisgen R, Uzun H. DNA Methylation Biomarkers in Cancer: Current Clinical Utility and Future Perspectives. Biomarkers Med. 2022:95. doi: 10.12998/wjcc. v6. i15.869. PMid: 30568941; PMCid: PMC6288499.

61. Wang H, Tang J, Ding Y, Guo F. Exploring associations of non-coding RNAs in human diseases via three-matrix factorization with hypergraph-regular terms on center kernel alignment. Briefings Bioinform. 2021; 22(5): bbaa409. doi: 10.1093/bib/bbaa409. PMid: 33443536.

62. Al Aboud NM, Tupper C, Jialal I. Genetics, epigenetic mechanism. 2018. PMid: 30422591.

63. Ganesan A. Epigenetics: the first 25 centuries. The Royal Society; 2018.5;373(1748):20170067. doi: 10.1098/rstb.2017.0067. PMid: 29685971; PMCid: PMC5915711.

64. Irungu S, Mavrelos D, Worthington J, Blyuss O, Saridogan E, Timms JF. Discovery of non-invasive biomarkers for the diagnosis of endometriosis. Clin Proteomics 2019; 16(1): 14. doi: 10.1186/s12014-019-9235-3. PMid: 30992697; PMCid: PMC6451201.

65. Socolov R, Butureanu S, Angioni S, Sindilar A, Boiculese L, Cozma L, et al. The value of serological markers in the diagnosis and prognosis of endometriosis: a prospective case–control study. Eur J Obstet Gynecol Reprod Biol 2011; 154(2): 215-7. doi: 10.1016/j.ejogrb.2010.10.008. PMid: 21075501.

66. Oikonomou M, Pergialiotis V, Goula K, Chrelias G, Chrelias C, Moutsatsou P, et al. Correlation of serum CA-125, CA 19–9, CEA and CA 15.3 in endometrial cancer with the histological grade. Eur J Obstetrics Gynecol Reproductive Biol 2019; 234: e88. doi.org/10.1016/j.ejogrb.2018.08.350.

67. Wei-Chun C, Chang TC, Cheng CM. Urinary analysis of biomarkers in endometriosis. 2020 (Abstract): 236 doi.org/10.11239/jsmbe.Annual58.236.

68. Check JH. CA-125 as a biomarker for malignant transformation of endometriosis. Fertility and sterility. 2009; 91(5): e35. doi: 10.1016/j.fertnstert.2009.02.036. PMid: 19338996.

69. Patel BG, Lenk EE, Lebovic DI, Shu Y, Yu J, Taylor RN. Pathogenesis of endometriosis: Interaction between Endocrine and inflammatory pathways. Best Pract Res Clin Obstet Gynaecol 2018; 50: 50-60. doi:10.1016/j.bpobgyn.2018.01.006. PMid: 29576469.

70. May KE, Conduit-Hulbert SA, Villar J, Kirtley S, Kennedy SH, Becker CM. Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update. 2010;16(6):651-74. doi: 10.1093/humupd/dmq009. PMid: 20462942; PMCid: PMC2953938.

71. Mabrouk M, Elmakky A, Caramelli E, Farina A, Mignemi G, Venturoli S, et al. Performance of peripheral (serum and molecular) blood markers for diagnosis of endometriosis. Arch Gynecol Obstet 2012; 285(5): 1307-12. doi: 10.1007/s00404-011-2122-4. PMid: 22065163.

72. Ozhan E, Kokcu A, Yanik K, Gunaydin M. Investigation of diagnostic potentials of nine different biomarkers in endometriosis. Eur J Obstet Gynecol Reprod Biol 2014; 178:128-33. doi: 10.1016/j.ejogrb.2014.04.037. PMid: 24813083.

73. Liu Y, Li M. TSP1-CD47-SIRPα signaling facilitates the development of endometriosis by mediating the survival of ectopic endometrium. 2020; 83(6): e13236. doi: 10.1111/aji.13236. PMid: 32196807.

74. Li J, Yan S, Li Q, Huang Y, Ji M, Jiao X, et al. Macrophage-associated immune checkpoint CD47 blocking ameliorates endometriosis. 2022; 28(5). doi: 10.1093/molehr/gaac010. PMid: 35404426.

75. Moreno-Moya JM, Vilella F, Simón C. MicroRNA: key gene expression regulators. Fertil Steril. 2014; 101 (6):1516-23. doi:10.1016/j.fertnstert.2013.10.042. PMid: 24314918.

76. Bjorkman S, Taylor HS. MicroRNAs in endometriosis: biological function and emerging biomarker candidates. Biol Reprod. 2019; 101(6): 1167-78. doi: 10.1093/biolre/ioz014. PMid: 30721951; PMCid: PMC6497525.

77. Scalici E, Hamamah S. Reply: Cell-free nucleic acids as non-invasive biomarkers of gynecological disorders, fetal aneuploidy and constitutional maternal chromosomal mosaicism. Hum Reprod Update. 2015; 21(5): 692. doi: 10.1093/humupd/dmv014. PMid: 257658.

78. Zhang M, Wang S, Tang L, Wang X, Zhang T, Xia X, et al. Downregulated circular RNA hsa_circ_0067301 regulates epithelial-mesenchymal transition in endometriosis via the miR-141/Notch signaling pathway. Biochem Biophysic Res Commun 2019; 514(1):71-7. doi: 10.1016/j.bbrc.2019.04.109. PMid: 31023528.

79. Hu W, Xie Q, Xu Y, Tang X, Zhao H. Integrated bioinformatics analysis reveals function and regulatory network of miR-200b-3p in endometriosis. BioMed Res Int. 2020: 3962953. doi: 10.1155/2020/3962953. PMid: 32802844; PMCid: PMC7414375.

80. Wang F, Wang H, Jin D, Zhang Y. Serum miR-17, IL-4, and IL-6 levels for diagnosis of endometriosis. Medicine 2018; 97(24). doi: 10.1097/MD.0000000000010853. PMid: 29901577; PMCid: PMC6023682.

81. Rekker K, Saare M, Roost AM, Kaart T, Sõritsa D, Karro H, et al. Circulating miR-200–family micro-RNAs have altered plasma levels in patients with endometriosis and vary with blood collection time. Fertil Steril 2015; 104(4): 938-46. e2. doi: 10.1016/j.fertnstert.2015.06.029. PMid: 26206343.

82. Saare M, Rekker K, Laisk-Podar T, Rahmioglu N, Zondervan K, Salumets A, et al. Challenges in endometriosis miRNA studies—From tissue heterogeneity to disease specific miRNAs. Biochim Biophys Acta Mol Basis Dis. 2017;1863(9):2282-92. doi: 10.1016/j.bbadis.2017.06.018. PMid: 28651916.

83. Hamberg M, Backes C, Fehlmann T, Hart M, Meder B, Meese E, et al. MiRTargetLink—miRNAs, genes and interaction networks. Int J Mol Sci 2016; 17(4): 564. doi: 10.3390/ijms17040564. PMid: 27089332; PMCid: PMC4849020.

84. Estella C, Herrer I, Moreno-Moya JM, Quiñonero A, Martínez S, Pellicer A, et al. miRNA signature and Dicer requirement during human endometrial stromal decidualization in vitro. PloS One 2012; 7(7): e41080. doi: 10.1371/journal.pone.0041080. PMid: 22911744; PMCid: PMC3401238.

85. Tochigi H, Kajihara T, Mizuno Y, Mizuno Y, Tamaru S, Kamei Y, et al. Loss of miR-542-3p enhances IGFBP-1 expression in decidualizing human endometrial stromal cells. Sci Rep. 2017; 7: 40001. doi: 10.1038/srep40001. PMid: 28051155; PMCid: PMC5209665.

86. Sun R, Liu J, Nie S, Li S, Yang J, Jiang Y, et al. Construction of miRNA-mRNA Regulatory Network and Prognostic Signature in Endometrial Cancer. 2021; 14:2363-78. doi: 10.2147/OTT.S272222. PMid: 33854334; PMCid: PMC8039850.

87. Zhang L, Li H, Yuan M, Li D. Serum Exosomal MicroRNAs as Potential Circulating Biomarkers for Endometriosis. 2020; 2020:2456340. doi: 10.1155/2020/2456340. PMid: 32076458; PMCID: PMC7008302.

88. Jia SZ, Yang Y, Lang J, Sun P, Leng J. Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis. Hum Reprod (Oxford, England). 2013; 28(2): 322-30. doi: 10.1093/humrep/des413. PMid: 23203215; PMCid: PMC3733164.

89. Ramón LA, Braza-Boïls A, Gilabert-Estellés J, Gilabert J, España F, Chirivella M, et al. microRNAs expression in endometriosis and their relation to angiogenic factors. Hum Reprod. 2011; 26(5):1082-90. doi: 10.1093/humrep/der025. PMid: 21335415.

90. Inomata M, Tagawa H, Guo YM, Kameoka Y, Takahashi N, Sawada K. MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood 2009;113(2):396-402. doi: 10.1182/blood-2008-07-163907. PMid: 18941111.

91. Cloonan N, Brown MK, Steptoe AL, Wani S, Chan WL, Forrest AR, et al. The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition. Genome Biol 2008; 9(8):1-14. doi: 10.1186/gb-2008-9-8-r127. PMid: 18700987; PMCid: PMC2575517.

92. Flores I, Rivera E, Ruiz LA, Santiago OI, Vernon MW, Appleyard CB. Molecular profiling of experimental endometriosis identified gene expression patterns in common with human disease. Fertil Steril. 2007; 87(5): 1180-99. doi: 10.1016/j.fertnstert.2006.07.1550. PMid: 17478174; PMCID: PMC1927082.

93. Suryawanshi S, Vlad AM, Lin HM, Mantia-Smaldone G, Laskey R, Lee M, et al. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res 2013; 19(5):1213-24. doi: 10.1158/1078-0432.CCR-12-2726. PMid: 23362326; PMCid: PMC3596045.

94. Wang WT, Zhao YN, Han BW, Hong SJ, Chen YQ. Circulating microRNAs identified in a genome-wide serum microRNA expression analysis as noninvasive biomarkers for endometriosis. J Clin Endocrinol Metabol 2013; 98(1):281-9. doi: 10.1210/jc.2012-2415. PMid: 23118427.

95. Cosar E, Mamillapalli R, Ersoy GS, Cho S, Seifer B, Taylor HS. Serum microRNAs as diagnostic markers of endometriosis: a comprehensive array-based analysis. Fertil Steril 2016;106(2):402-9. doi: 10.1016/j.fertnstert.2016.04.013. PMid: 27179784.

96. Aghajanova L, Giudice LC. Molecular evidence for differences in endometrium in severe versus mild endometriosis. Reprod Sci. 2011; 18(3):229-51. doi: 10.1177/1933719110386241. PMid: 21063030; PMCID: PMC3118406.

97. Petracco R, Grechukhina O, Popkhadze S, Massasa E, Zhou Y, Taylor HS. MicroRNA 135 regulates HOXA10 expression in endometriosis. J Clin Endocrinol Metabol 2011;96(12): E1925-E33. doi: 10.1210/jc.2011-1231. PMid: 21956427; PMCid: PMC3232619.

98. Liu Y, Chen J, Zhu X, Tang L, Luo X, Shi Y. Role of miR‑449b‑3p in endometriosis via effects on endometrial stromal cell proliferation and angiogenesis. Mole Med Rep. 2018; 18(3):3359-65. doi: 10.3892/mmr.2018.9341. PMid: 30066926; PMCid: PMC6102748.

99. Liu S, Xin W, Tang X, Qiu J, Zhang Y, Hua K. LncRNA H19 overexpression in endometriosis and its utility as a novel biomarker for predicting recurrence. Reprod Sci 2020; 27(9):1687-97. doi: 10.1007/s43032-019-00129-x. PMid: 32468268.

100. Zhang L, Yu Z, Qu Q, Li X, Lu X, Zhang H. Exosomal lncRNA HOTAIR Promotes the Progression and Angiogenesis of Endometriosis via the miR-761/HDAC1 Axis and Activation of STAT3-Mediated Inflammation. Int J Nanomed. 2022; 17:1155-70. doi: 10.2147/IJN.S354314. PMid: 35321026; PMCID: PMC8935629.

101. Wu J, Huang H, Huang W, Wang L, Xia X. Analysis of exosomal lncRNA, miRNA and mRNA expression profiles and ceRNA network construction in endometriosis. 2020; 12(14):1193-213. doi: 10.2217/epi-2020-0084. PMid: 32462942.

102. Montgomery GW, Mortlock S, Giudice LC. Should genetics now be considered the pre-eminent etiologic factor in endometriosis? J Minim Invasive Gynecol 2020;27(2):280-6. doi: 10.1016/j.jmig.2019.10.020. PMid: 31683028; PMCid: PMC7863762

103. Ballard K, Lowton K, Wright J. What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis. Fertil Steril 2006; 86(5):1296-301. doi: 10.1016/j.fertnstert.2006.04.054. PMid: 17070183.

104. Fassbender A, Vodolazkaia A, Saunders P, Lebovic D, Waelkens E, De Moor B, et al. Biomarkers of endometriosis. Fertil Steril 2013; 99(4):1135-45. doi: 10.1016/j.fertnstert.2013.01.097. PMid: 23414923.

105. Zheng X, Xu K, Zhu L, Mao M, Zhang F, Cui L. MiR-486-5p Act as a Biomarker in Endometrial Carcinoma: Promotes Cell Proliferation, Migration, Invasion by Targeting MARK1. Onco Targets Ther. 2020; 13: 4843-53. doi: 10.2147/OTT.S246841. PMid: 32547110; PMCid: PMC7266516.

106. Zhou CF, Liu MJ, Wang W, Wu S, Huang YX, Chen GB, et al. Correction to: miR-205-5p inhibits human endometriosis progression by targeting ANGPT2 in endometrial stromal cells. Stem Cell Res Ther 2020; 11(1): 188. doi: 10.1186/s13287-020-01686-8. PMid: 32434593; PMCid: PMC7238729.

107. He Y, Li J, Qu Y, Sun L, Zhao X, Wu H, Zhang G. Identification and Analysis of Potential Immune-Related Biomarkers in Endometriosis. J Immunol Res 2023; 2023:2975581. doi: 10.1155/2023/2975581. PMid: 36660246; PMCid: PMC9845045.

108. Tahermanesh K, Hakimpour S, Govahi A, Rokhgireh S, Mehdizadeh M, Minaeian S, et al. Evaluation of expression of biomarkers of PLAGL1 (ZAC1), microRNA, and their non-coding RNAs in patients with endometriosis. J Gynecol Obstet Hum Reprod. 2023; 52(4): 102568. doi: 10.1016/j.jogoh.2023.102568. PMid: 36868502.

109. Gao S, Liu S, Gao ZM, Deng P, Wang DB. Reduced microRNA-451 expression in eutopic endometrium contributes to the pathogenesis of endometriosis. World J Clin Cases 2019; 7(16): 2155-2164. doi: 10.12998/wjcc.v7.i16.2155. PMid: 31531311; PMCid: PMC6718782.

110. Zhang L, Yu Z, Qu Q, Li X, Lu X, Zhang H. Exosomal lncRNA HOTAIR Promotes the Progression and Angiogenesis of Endometriosis via the miR-761/HDAC1 Axis and Activation of STAT3-Mediated Inflammation. Int J Nanomed 2022; 17: 1155-1170. doi: 10.2147/IJN.S354314. PMid: 35321026; PMCid: PMC8935629.

111. Janša V, Pušić Novak M, Ban Frangež H, Rižner TL. TGFBI as a candidate biomarker for non-invasive diagnosis of early-stage endometriosis. Hum Reprod. 2023; 38(7): 1284-96. doi: 10.1093/humrep/dead091. PMid: 37187159; PMCid: PMC10320490.

112. Huang H, Zhu Z, Song Y. Downregulation of lncrna uca1 as a diagnostic and prognostic biomarker for ovarian endometriosis. Rev Assoc Med Bras 2019; 65(3): 336-341. doi: 10.1590/1806-9282.65.3.336. PMid: 30994830.

113. Shan S, Yang Y, Jiang J, Yang B, Yang Y, Sun F, Zhang J, Lin Y, Xu H. Extracellular vesicle-derived long non-coding RNA as circulating biomarkers for endometriosis. Reprod Biomed Online 2022; 44(5): 923-33. doi: 10.1016/j.rbmo.2021.11.019. PMid: 35341703.

114. Yu J, Jiang L, Gao Y, Sun Q, Liu B, Hu Y, et al. LncRNA CCAT1 negatively regulates miR-181a-5p to promote endometrial carcinoma cell proliferation and migration. Exp Ther Med. 2019; 17(5): 4259-66. doi: 10.3892/etm.2019.7422. PMid: 30988798; PMCid: PMC6447908.

115. Li L, Ye K, Wang D. Upregulation of HTRA1 mediated by the lncRNA NEAT1/miR-141-3p axis contributes to endometriosis development through activating NLRP3 inflammasome-mediated pyroptotic cell death and cellular inflammation. In Vitro Cell Dev Biol Anim 2023; 59(3):166-178. doi: 10.1007/s11626-023-00760-8. PMid: 37017808.

116. Kumari P, Sharma I, Saha SC, Srinivasan R, Bhardwaj P. Role of serum microRNAs as biomarkers for endometriosis, endometrioid carcinoma of ovary & endometrioid endometrial cancer. Indian J Med Res 2022; 156(3): 516. doi: 10.4103/ijmr.IJMR_288_20. PMid: 36751747; PMCid: PMC10101355.

117. Nematian SE, Mamillapalli R, Kadakia TS, Majidi Zolbin M, Moustafa S, Taylor HS. Systemic inflammation induced by microRNAs: endometriosis-derived alterations in circulating microRNA 125b-5p and Let-7b-5p regulate macrophage cytokine production. J Clin Endocrinol Metabol 2018; 103(1):64-74. doi: 10.1210/jc.2017-01199. PMid: 29040578.

118. Song Y, Huang R, Hu X, Wu S, Chen S, Liu G, et al. Downregulation of lncRNA LINC01465 predicts ovarian endometriosis and its prognosis. Wiener klinische Wochenschrift. 2023:1-6. doi: 10.1007/s00508-023-02219-y. PMid: 37256422.

119. Szaflik T, Romanowicz H, Szyłło K, Smolarz B. Long Non-Coding RNA SNHG4 Expression in Women with Endometriosis: A Pilot Study. Genes. 2023; 14(1):152. doi: 10.3390/genes14010152. PMid: 36672893; PMCid: PMC9859099.

120. Kizilgedik DF, Caner A, Yildiz Ç, Okşaşoğlu B, Misir S, Yaylim I, et al. Investigation of Galectin-3 Levels of Endometriosis Patients According to Stages. Experimed. 2023; 13(1):15-20. doi.org/10.26650/experimed.1148905.